Polyphenon E
Sponsors
Jonsson Comprehensive Cancer Center, Mayo Clinic, Sherry Chow, H. Lee Moffitt Cancer Center and Research Institute, Louisiana State University Health Sciences Center Shreveport
Conditions
Bladder CancerBreast CancerDuctal Carcinoma in SituHIV InfectionLeukemiaLung Cancer PreventionMultiple SclerosisNon-Small Cell Lung Cancer
Phase 1
Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
CompletedNCT00262743
Start: 2005-08-31End: 2012-08-31Updated: 2013-05-30
Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer
TerminatedNCT00707252
Start: 2008-01-31End: 2012-11-30Updated: 2015-04-21
Safety of Polyphenon E in Multiple Sclerosis Pilot Study
CompletedNCT00836719
Start: 2009-02-28End: 2010-11-30Updated: 2013-06-27
Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals
CompletedNCT01433289
Start: 2010-12-31End: 2015-07-31Updated: 2023-05-19
Phase 2
Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
CompletedNCT00088946
Start: 2004-05-31End: 2006-07-31Updated: 2020-07-31
Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease
CompletedNCT00363805
Start: 2004-05-31Updated: 2013-11-28
Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia
CompletedNCT00596011
Start: 2007-11-14End: 2018-07-27Updated: 2019-10-04
A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression
CompletedNCT00676793
Start: 2004-05-31End: 2013-07-31Updated: 2017-09-21
A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ
TerminatedNCT01060345
Start: 2010-05-31End: 2015-09-30Updated: 2020-04-09
Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II
TerminatedNCT01451723
Start: 2011-07-31End: 2013-02-28Updated: 2014-03-14